Anthem Biosciences Ltd
Anthem Biosciences Ltd Live Price Chart
Anthem Biosciences Ltd Technicals
| 20 Day | ₹ 617.404 |
| 50 Day | ₹ 639.559 |
| 100 Day | ₹ 684.652 |
| 200 Day | ₹ 716.930 |
| 20 Day | ₹ 610.225 |
| 50 Day | ₹ 639.305 |
| 100 Day | ₹ 689.639 |
| 200 Day | ₹ 0.000 |
Anthem Biosciences Ltd Performance
| Previous Close | ₹ 635 |
| High | ₹ 656.6 |
| Volume | 316986 |
| 52W Range | ₹ 579.15 - ₹ 873.5 |
| Open | ₹ 627 |
| Low | ₹ 623.15 |
| Market Cap | ₹ 37151 Cr |
Anthem Biosciences Ltd Fundamentals
| ROCE | 28.267 |
| P/E Ratio | 63.120 |
| P/B Ratio | 12.860 |
| Industry P/E | 12.860 |
| Debt to Equity | 39.451 |
| ROE | 20.933 |
| EPS | 10.350 |
| Dividend Yield | 0.000 |
| Book Value | 50.801 |
| Face Value | 2.000 |
Anthem Biosciences Ltd Financials
| Particulars | Y202503 | Y202403 | Y202303 | Y202203 | Y202103 |
|---|---|---|---|---|---|
| Total Revenue | 1950.0888 | 1488.0587 | 1134.296 | 1280.2366 | 1140.4494 |
| Total Expenses | 1238.6657 | 1003.2861 | 698.3157 | 733.6443 | 774.8702 |
| Profit After Tax | 506.1875 | 374.7806 | 385.6711 | 405.9903 | 271.3062 |
Anthem Biosciences Ltd Shareholding Pattern
| Promoter Holdings | 74.690 % |
| FIIs | 1.364 % |
| DIIs | 0.705 % |
| MutualFund | 6.893 % |
| Retail | 9.603 % |
| Others - | 6.745 % |
About Anthem Biosciences Ltd
History of Anthem Biosciences Ltd
Anthem Biosciences Limited was originally incorporated as 'Anthem Biosciences Private Limited', dated June 13, 2006, issued by RoC. Subsequently, Company was converted from a Private Company to a Public Company , followed by the change in name of the Company to 'Anthem Biosciences Limited' and a Certificate of Incorporation was issued by RoC on December 10, 2024. The Company has been set up as a Life sciences/ Biotechnology based venture specialising in the manufacture of catalytic preparation, other organic compounds such as speciality organic molecules, biologically active peptides etc., which are high-value products used in drug, agrochemical and speciality chemicals industries. The Company started operations at Unit I and set up a Custom Synthesis Plant with a capacity of 6 KL in year 2007. It commenced discovery biology services with a fermentation capacity of 2 KL in 2008. It expanded the Custom Synthesis Plant at Unit I increasing its capacity from 6 KL to 24 KL in 2010. It set up a high potent lab at Unit I - Bommasandra Facility in 2016. The Company was merged with Anthem Cellutions (India) Private Limited by acquiring 100% of its share capital in November, 2017. It set up a flow chemistry lab scale and solid phase peptide synthesis GMP lab with a capacity of 6 KL at Unit 1. It commenced operations of the Company at Unit II and set up an automated GMP compliant custom synthesis plant with a capacity of 128 KL and a fermentation plant with a capacity of 80 KL in ...
